Douglas L Arnold Selected Research

Protons (Proton)

11/2009	The metabolic epicenter of supratentorial gliomas: a 1H-MRSI study.
10/2008	Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
8/2006	Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging.
1/2006	Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
11/2005	1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.
2/2004	The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
9/2003	Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas.
3/2003	Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas L Arnold Research Topics

Disease

84	Multiple Sclerosis 10/2022 - 02/2005
42	Relapsing-Remitting Multiple Sclerosis 01/2022 - 02/2008
15	Atrophy 01/2022 - 05/2004
13	Infections 01/2021 - 05/2011
11	Chronic Progressive Multiple Sclerosis 09/2022 - 01/2017
8	Inflammation (Inflammations) 01/2022 - 07/2006
7	Disease Progression 01/2022 - 04/2002
7	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2006
5	Neoplasms (Cancer) 01/2017 - 09/2003
4	Headache (Headaches) 01/2019 - 07/2014
3	Optic Neuritis (Retrobulbar Neuritis) 05/2022 - 04/2016
3	Ganglion Cysts (Ganglion) 05/2022 - 11/2019
3	Nasopharyngitis 12/2021 - 04/2016
3	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 07/2014
3	Glioma (Gliomas) 11/2009 - 09/2003
2	Abdominal Pain (Pain, Abdominal) 12/2021 - 09/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 01/2017
2	Atrioventricular Block 11/2019 - 04/2016
2	Human Influenza (Influenza) 01/2019 - 07/2014
2	Bradycardia 10/2018 - 01/2018
2	Body Weight (Weight, Body) 01/2018 - 09/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2012 - 11/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2006 - 03/2003
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Pancreatitis 12/2021
1	Alopecia (Baldness) 12/2021
1	Myelitis 10/2021
1	Macular Edema 06/2021
1	Opportunistic Infections (Opportunistic Infection) 11/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Herpes Zoster 01/2018
1	Supraventricular Tachycardia 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2018
1	Leukopenia 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Chickenpox 01/2018
1	Neuroinflammatory Diseases 04/2017

Drug/Important Bio-Agent (IBA)

16	GadoliniumIBA 01/2022 - 02/2008
14	Dimethyl FumarateIBA 01/2022 - 09/2012
12	Interferon beta-1a FDA Link 01/2021 - 11/2012
9	peginterferon beta-1aIBA 01/2022 - 07/2014
9	Glatiramer Acetate (Copaxone)FDA Link 08/2020 - 02/2005
8	ozanimodIBA 10/2022 - 04/2016
8	Protons (Proton)IBA 11/2009 - 03/2003
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2002
6	InterferonsIBA 02/2021 - 07/2014
6	Alemtuzumab (Campath)FDA Link 01/2021 - 11/2012
6	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 01/2018
6	ocrelizumabIBA 12/2020 - 01/2017
5	Myelin-Oligodendrocyte GlycoproteinIBA 10/2022 - 01/2018
5	Sphingosine-1-Phosphate ReceptorsIBA 09/2022 - 04/2016
4	siponimodIBA 09/2022 - 01/2018
3	Retinaldehyde (Retinal)IBA 05/2022 - 11/2019
3	Natalizumab (Tysabri)FDA Link 01/2022 - 01/2018
3	FumaratesIBA 01/2022 - 02/2014
3	EnzymesIBA 12/2021 - 01/2021
3	AntibodiesIBA 01/2020 - 08/2016
3	Biological ProductsIBA 01/2020 - 12/2014
3	Transaminases (Aminotransferases)IBA 01/2018 - 09/2012
3	CreatineIBA 11/2005 - 09/2003
2	diroximel fumarateIBA 01/2022 - 11/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2019
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2018 - 04/2016
2	amiselimodIBA 10/2018 - 10/2016
2	Interferon beta-1b (Betaseron)FDA Link 08/2017 - 08/2016
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 07/2006
2	Indicators and Reagents (Reagents)IBA 12/2014 - 02/2005
2	Pharmaceutical PreparationsIBA 07/2014 - 05/2007
2	Monoclonal AntibodiesIBA 11/2012 - 11/2012
2	Interferon-betaIBA 11/2012 - 04/2005
2	Choline (Choline Chloride)IBA 11/2009 - 09/2003
2	N-acetylaspartate (N-acetyl aspartate)IBA 05/2004 - 02/2004
1	Immunoglobulin G (IgG)IBA 10/2022
1	Cytidine Diphosphate (CDP)IBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2021
1	teriflunomideIBA 12/2021
1	AdiponectinIBA 10/2021
1	anti-aquaporin 4 autoantibodyIBA 10/2021
1	AdipokinesIBA 10/2021
1	Protein Isoforms (Isoforms)IBA 10/2021
1	ImmunosorbentsIBA 10/2021
1	Daclizumab (Zenapax)FDA Link 01/2021
1	AutoantibodiesIBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 10/2019
1	evobrutinibIBA 01/2019
1	opicinumabIBA 01/2019
1	Busulfan (Busulfex)FDA Link 01/2018
1	Abatacept (Orencia)FDA Link 04/2017

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 10/2008
4	Hematopoietic Stem Cell Transplantation 01/2020 - 08/2010
3	Cell Transplantation 09/2021 - 02/2015
3	Injections 01/2018 - 07/2014
2	Stem Cell Transplantation 08/2016 - 02/2008
1	Immunomodulation 01/2020
1	Retreatment 10/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2017